|
STMN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.739700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.565640E-02 |
| Normal-vs-Stage2 |
9.566600E-01 |
| Normal-vs-Stage3 |
4.698000E-01 |
| Normal-vs-Stage4 |
1.185380E-01 |
| Stage1-vs-Stage2 |
3.005800E-02 |
| Stage1-vs-Stage3 |
3.495400E-01 |
| Stage1-vs-Stage4 |
2.000600E-03 |
| Stage2-vs-Stage3 |
4.994400E-01 |
| Stage2-vs-Stage4 |
1.531430E-01 |
| Stage3-vs-Stage4 |
1.127000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.956900E-03 |
| Normal-vs-AfricanAmerican |
7.248000E-01 |
| Normal-vs-Asian |
5.948000E-01 |
| Caucasian-vs-AfricanAmerican |
5.076500E-03 |
| Caucasian-vs-Asian |
7.758200E-01 |
| AfricanAmerican-vs-Asian |
5.163400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.356300E-02 |
| Normal-vs-Female |
7.250000E-02 |
| Male-vs-Female |
6.929000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.636800E-01 |
| Normal-vs-Extreme_Weight |
8.707600E-02 |
| Normal-vs-Obese |
4.857800E-02 |
| Normal-vs-Extreme_Obese |
7.273600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.527400E-01 |
| Normal_Weight-vs-Obese |
2.738400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.878000E-01 |
| Extreme_Weight-vs-Obese |
5.752000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.553600E-01 |
| Obese-vs-Extreme_Obese |
4.479800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.317600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.840000E-03 |
| Normal-vs-Age(61-80Yrs) |
3.242200E-02 |
| Normal-vs-Age(81-100Yrs) |
9.468200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.548500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.630300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.233000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.229400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.504240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.137440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.45589999999996E-05 |
| Normal-VS-Type2 PRCC |
4.915200E-01 |
| Normal-VS-KIRP CIMP |
1.94419999999251E-05 |
| Normal-VS-Unclassified PRCC |
4.277600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.2311000803561E-10 |
| Type1 PRCC-VS-KIRP CIMP |
1.29440003160397E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
1.414050E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.06059999999786E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.482770E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.92249999978011E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.193000E-01 |
| Normal-vs-N1 |
6.383600E-01 |
| Normal-vs-N2 |
2.204200E-01 |
| N0-vs-N1 |
9.685800E-01 |
| N0-vs-N2 |
2.399600E-01 |
| N1-vs-N2 |
3.790000E-01 |
|
|
